alexa BTK’s Remarkable Efficacy in B Cell Malignancies

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

BTK’s Remarkable Efficacy in B Cell Malignancies

Bruton’s tyrosine kinase (BTK), a member of the Tec family of protein tyrosine kinases (PTKs), plays a vital and diverse function in many cellular processes. BTK is expressed throughout B cell development, widely participating in multiple signal pathways.Those pathways play critical functions in cell proliferation, development, differentiation, survival, and apoptosis. Targeting BTK has achieved remarkable efficacy in B cell malignancies, multiple myeloma and related bone disease.


Citation: Liu Y, Zhou G, Zhang B, Liu Y (2013) Bruton’s Tyrosine Kinase: Structure and Functions, Expression and Mutations. Gene Technology 2:106.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger